Liminal BioSciences Inc.,[1] formerly known as Prometic Life Sciences Inc.,[2] is a Canadian biopharmaceutical company.
History
- Liminal[3] was founded in 1988, as a commercial spinoff of research at the University of Cambridge on affinity chromatography.[4] Its founder was the current President and CEO, Pierre Laurin, whose research formed the basis for the company's products.[4] Liminal was incorporated on October 14, 1994 under the Canada Business Corporations Act, or the CBCA, under the name Innovon Life Sciences Holdings Limited.